Market Place
Sourcing Support
Pathalys raises $105M to prepare Japan-approved kidney disease drug for FDA
21 Aug 2024 //
FIERCE BIOTECH
Pathalys Pharma Appoints Dr. Bastian Dehmel as Chief Medical Officer
13 Aug 2024 //
PR NEWSWIRE
Pathalys and Launch Announce Patient Enrolled in Phase 3 Program for Upacicalcet
31 May 2023 //
PR NEWSWIRE
Pathalys Raises $150M in Secured Product Financing and Equity led by Abingworth
18 Jan 2023 //
PR NEWSWIRE
Pathalys inks development deal with Abingworth company, raising $150M
18 Jan 2023 //
ENDPTS
Pathalys Pharma to Present at Jefferies Healthcare Conference
02 Jun 2022 //
PRNEWSWIRE
Pathalys Pharma to Present at Needham Virtual Healthcare Conference
08 Apr 2022 //
PRNEWSWIRE
Pathalys Pharma Announces Phase 3 Program for Upacicalcet
07 Apr 2022 //
PRNEWSWIRE
Pathalys Pharma Announces Executive Team Appointments
30 Mar 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.